Monteris Medical has announced it has secured $30 million in series B financing.

Monteris, headquartered in Plymouth, Minn., is a developer of minimally invasive laser systems for the ablation of pathologic brain lesions such as primary and metastatic tumors.

The funding round was led by new investor Birchview Capital. Also participating in the round was new investor The Vertical Group and existing investor BDC Capital Healthcare Fund.

Monteris indicated the financing would go toward supporting an expansion of commercial and clinical programs for the Monteris NeuroBlate robotic neurosurgical system.